Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gallardo

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Oncotarget|October 6, 2015
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signatureMarina Díaz-Beyá, Salut Brunet, Josep Nomdedéu, et al.
American Journal of Clinical Pathology|August 16, 2015
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AMLMaria Concepcion García-Dabrio, Montserrat Hoyos, Salut Brunet, et al.
Frontiers in Immunology|February 6, 2023
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donorsDavid Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, et al.
Transplantation|April 17, 2004
Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host diseaseDavid Gallardo, Salut Brunet, Antonio Torres, et al.
Assessment|June 26, 2020
Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical SampleFernando Gutiérrez, Anton Aluja, José Ruiz, et al.
European Journal of Haematology|September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogeneticsJohana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Leukemia & Lymphoma|January 19, 2018
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survivalVicent Guillem, Marisa Calabuig, Salut Brunet, et al.
Blood Advances|July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphismsCarolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Plos One|October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationVíctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Blood Advances|December 15, 2021
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocolAlex Bataller, Ana Garrido, Francesca Guijarro, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Oncotarget|October 6, 2015
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signatureMarina Díaz-Beyá, Salut Brunet, Josep Nomdedéu, et al.
American Journal of Clinical Pathology|August 16, 2015
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AMLMaria Concepcion García-Dabrio, Montserrat Hoyos, Salut Brunet, et al.
Frontiers in Immunology|February 6, 2023
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donorsDavid Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, et al.
Transplantation|April 17, 2004
Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host diseaseDavid Gallardo, Salut Brunet, Antonio Torres, et al.
Assessment|June 26, 2020
Personality Disorders in the ICD-11: Spanish Validation of the PiCD and the SASPD in a Mixed Community and Clinical SampleFernando Gutiérrez, Anton Aluja, José Ruiz, et al.
European Journal of Haematology|September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogeneticsJohana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Leukemia & Lymphoma|January 19, 2018
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survivalVicent Guillem, Marisa Calabuig, Salut Brunet, et al.
Blood Advances|July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphismsCarolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Plos One|October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationVíctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Blood Advances|December 15, 2021
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocolAlex Bataller, Ana Garrido, Francesca Guijarro, et al.
Pageof 11